The systemic immune-inflammatory index in high-risk patients with hypertension: a cross sectional-study

Francelise Susan Mihara Bettanin1, Marcelo Rodrigues Bacci2

  • 1Student, Programa de Pós-Graduação em Ciências da Saúde, Centro Universitário Faculdade de Medicina ABC; Nurse, Centro Universitário Faculdade de Medicina ABC, Santo André (SP), Brazil.

Insights

The systemic immune-inflammatory index (SII) correlates with hypertension risk factors. Higher SII indicates older age and poorer kidney function in high-risk hypertensive patients, suggesting its use in screening.

Area of Science:

  • Cardiology
  • Nephrology
  • Immunology

Background:

  • Essential hypertension is a major cause of cardiovascular and kidney disease.
  • Inflammation and oxidative stress contribute to hypertension-related organ damage.
  • The systemic immune-inflammatory index (SII) is a potential biomarker, but its link to hypertension risk factors needs clarification.

Purpose of the Study:

  • To investigate the association between the systemic immune-inflammatory index (SII) and traditional risk factors in patients with hypertension.

Main Methods:

  • A cross-sectional study involving 61 hypertensive patients in Bahia.
  • Collected demographic data, clinical information, and various biomarkers including SII and neutrophil/lymphocyte ratio (NLR).
  • Utilized bivariate and multivariate analyses to assess correlations.

Main Results:

  • A positive correlation was found between SII and NLR.
  • Multivariate analysis revealed that age, renal function, and NLR were positively associated with SII.
  • Framingham risk score did not correlate with SII in this cohort.

Conclusions:

  • The systemic immune-inflammatory index (SII) is a cost-effective tool for screening chronic conditions like hypertension.
  • Elevated SII is linked to increased age and impaired renal function in high-risk hypertensive individuals.
  • Inflammation plays a key role in vascular damage in hypertension.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
402
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
540
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
743